Title list by author names [The University of Osaka Biomedical R&D Seeds 2026]

• F
• H
• K
• M
• N
• O
• S
• T
• U
• W

F

• Development of a robot arm for bone processing (Department of Orthopaedic Surgery, Graduate School of Medicine, Associate Professor (Lecturer) Takahito FUJIMORI)

H

• Development of SE36-cVLP Malaria Vaccine (Laboratory of Malaria Vaccine Development, Research Institute of Microbial Diseases, Special Appointed Professor Toshihiro HORII)
• Restoration of Motor and Communication by Wireless Implantable Brain Machine Interfaces (Department of Neurological Diagnosis and Restoration, Graduate School of Medicine, Specially Appointed Professor Masayuki HIRATA)
• Development of gene therapy for arrhythmogenic right ventricular cardiomyopathy (Department of Cardiovascular Medicine, The University of Osaka Graduate School of Medicine, Associate Professor / Lecturer Shuichiro HIGO)

K

• Development of ASOs for multiple system atrophy (Department of Neurology, Graduate school of Medicine, Specially appointed Lecturer Yasuyoshi KIMURA, Osaka Toneyama Medical Center Director Hideki MOCHIZUKI)
• Establishment of a new strategy for the treatment of functional restoration in skeletal muscle injury by tissue engineering using osteopontinederived SVVYGLR peptide (Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Professor Susumu TANAKA)
• Development of a new disinfection device using Pernitric acid solution (Division of Sustainable Energy and Environmental Engineering, Graduate School of Engineering, Associate Professor Katsuhisa KITANO)
• Novel diagnostic marker to differentiate urogenital carcinoma by chiral amino acids in body fluids (Department of Urology Graduate School of Medicine, Associate Professor (Lecturer) Atsunari KAWASHIMA)
• Raman spectroscopic tissue detection for minimally-invasive and precise medicine (Institute for Open and Transdisciplinary Research Initiatives, Associate Professor Yasuaki KUMAMOTO)

M

• Development of novel companion PET diagnostics and therapeutic agents for myocarditis (Department of Medical Biochemistry, Graduate School of Medicine, Associate Professor Ken MATSUOKA)
• Development of oncolytic adenovirus agents composed of human adenovirus type 35 (Graduate School of Pharmaceutical Sciences, Professor Hiroyuki MIZUGUCHI)

N

• Development of L862, an Innovative Pulmonary Hypertension Treatment Targeting TRPC3/6 (Pharmaceutical Sciences, Associate Professor Ryu NAGATA, Shinshu University School of Medicine, Professor Koichiro KUWAHARA)

O

• A new anti-inflammatory drug that utilizes the active site of an endogenous NFkB direct inhibitory protein (Graduate School of Frontier Biosciences, Specially Appointed Associate Professor Kazuki OKAMOTO)

S

• Repair of incurable meniscal injuries using an aligned electrospun nanofibrous scaffold (Department of Orthopaedic Surgery, Graduate School of Medicine, Guest Professor Kazunori SHIMOMURA)

T

• Development of a new treatment for chemotherapy-resistant triple-negative breast cancer (Department of Advanced Molecular Therapy, Graduate School of Medicine, Professor Yoshiaki TANIYAMA)
• Establishment of a new strategy for the treatment of functional restoration in skeletal muscle injury by tissue engineering using osteopontinederived SVVYGLR peptide (Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Professor Susumu TANAKA)
• Development of a new disinfection device using Pernitric acid solution (Division of Sustainable Energy and Environmental Engineering, Graduate School of Engineering, Associate Professor Katsuhisa KITANO)
• Development of “peptide” pulp capping agent promoting wound healing process of pulp tissue (The University of Osaka Dental Hospital, Associate Professor (Lecturer) Yusuke TAKAHASHI)
• Development of Liver Assist Device Using Hypoimmunogenic Hepatocyte System (Graduate School of Medicine, Professor Takanori TAKEBE)

U

• Development of single-molecule imaging-based screening technology for drug discovery (Graduate School of Frontier Biosciences, Professor Masahiro UEDA)

W

• Targeted alpha-ray therapy for refractory thyroid cancer (Institute for Radiation Sciences, Associate Professor Tadashi WATABE)
• Innovative alpha therapy targeting PSMA for refractory prostate cancer (Institute for Radiation Sciences, Associate Professor Tadashi WATABE)

Return to Research Profiles page